FDA approves Dr. Reddy’s migraine injection

Dr Reddy's

Dr. Reddy’s, which is based in India, has announced that the FDA has approved its ZEMBRACE SymTouch injection, which is used to treat acute migraine episodes in adults. The drug will be markted in the US by Promius Pharma, which is a specialty firm owned in full by Dr. Reddy’s.

Read the source article at Wallstreet.org

About the Author

Related Posts

Leave a Reply